DrS's DERMATOLOGY WEBSITE

Ana Sayfa

Perşembe, 02 Eylül 2010

Ana Menü

LAST FULL ARTICLES

Psoriasis: a possible risk factor for development of coronary artery calcification

Community pharmacists’ role in managing common skin problems

Liquid injectable silicone for soft tissue augmentation

Collagen fillers

Hyaluronic acid fillers

Childhood acne: evaluation and management

Pediatric rozacea

Update in retinoid therapy of acne

Retinoid therapy of pigmentary disorders

The use of retinoids in the treatment of photoaging

Arşiv

E-maillist

Online Status

Online Contact

FLASH

Dermatoloji.com' un wap versionu olan "DrS's Dermatology Wapsite" http://wap.dermatoloji.com adresinde yayına girdi. Siteye wap uyumlu cep telefonu ve PDA lardan ulaşabilirsiniz

İletişim2

[Geri Dön]

YOUR INFORMATION

Last Books

FLASH NEWS

DNA From National Psoriasis Victor Henschel BioBank Released For Study
Millions of Americans struggling with psoriasis and psoriatic arthritis are one step closer to a cure with the first-ever release of National Psoriasis Victor Henschel BioBank DNA samples for use in psoriasis research. The samples will allow scientists to uncover the unknowns about the genetics of psoriatic disease and its causes. James T. Elder, M.D., Ph.D...

Bed Bugs On The Rise
Bed bugs appear to be on the rise around the world, as more and more experts and professionals in pest control report huge rises in prevalence, even so far as to suggest we are on the verge of a bed bug pandemic...

Half Of Brits Got Sunburnt This Year And Many Would Do It Again
A NEW survey released today (Wednesday 1 September) reveals almost half of Brits (46 per cent) got sunburnt this year. Of those who got burnt, a third (32 per cent) admitted their motivation was to get a tan. And half of those who burnt whilst trying to get a tan would risk burning again next year...

Lytix Biopharma AS Announces Approval By Hungarian Authorities To Start Phase IIa Clinical Trial With LytixarTM In Gram Positive Skin Infections
The Norwegian pharmaceutical company Lytix Biopharma AS today announces the approval in Hungary to commence a Phase IIa clinical trial with LytixarTM (LTX-109) treatment of skin infections caused by Gram positive bacteria...

Successful Treatment For S. aureus Skin Infection In Mouse Model
Scientists from the National Institutes of Health and University of Chicago have found a promising treatment method that in laboratory mice reduces the severity of skin and soft-tissue damage caused by USA300, the leading cause of community-associated Staphylococcus aureus infections in the United States...

TIME

Activities

September 2010

M	T	W	T	F	S	S
30	31	1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	1	2	3

This month

LAST ACTIVITIES

No Latest Events